These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28103573)

  • 1. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 4. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
    Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
    Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
    Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
    Wang Y; Xiao J; Zhao Y; Du S; Du J
    Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
    Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery.
    Liu XR; Liu F; Li ZW; Lv Q; Shu XP; Li LS; Tong Y; Zhang W; Peng D
    Nutr Cancer; 2023; 75(10):1926-1933. PubMed ID: 37870939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.
    Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH
    J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
    Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
    Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
    Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
    Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
    Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study.
    Huang WK; Chang SH; Hsu HC; Chou WC; Yang TS; Chen JS; Chang JW; Lin YC; Kuo CF; See LC
    Int J Cancer; 2020 Oct; 147(7):1904-1916. PubMed ID: 32196659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.